Non-invasive prenatal diagnosis (NIPD): current and emerging technologies

Abstract

Prenatal testing is important for the early detection and diagnosis of rare genetic conditions with life-changing implications for the patient and their family. Gaining access to the fetal genotype can be achieved using gold-standard invasive sampling methods, such as amniocentesis and chorionic villus sampling, but these carry a small risk of miscarriage. Non-invasive prenatal diagnosis (NIPD) for select rare monogenic conditions has been in clinical service in England since 2012 and has revolutionised the field of prenatal diagnostics by reducing the number of women undergoing invasive sampling procedures. Fetal-derived genomic material is present in a highly fragmented form amongst the maternal cell-free DNA (cfDNA) in circulation, with sequence coverage across the entire fetal genome. Cell-free fetal DNA (cffDNA) is the foundation for NIPD, and several technologies have been clinically implemented for the detection of paternally inherited and de novo pathogenic variants. Conversely, a low abundance of cffDNA within a high background of maternal cfDNA makes assigning maternally inherited variants to the fetal fraction a significantly more challenging task. Research is ongoing to expand available tests for maternal inheritance to include a broader range of monogenic conditions, as well as to uncover novel diagnostic avenues. This review covers the scope of technologies currently clinically available for NIPD of monogenic conditions and those still in the research pipeline towards implementation in the future.

Keywords

Cell-free DNA / non-invasive prenatal diagnosis / monogenic conditions

References

[1] Lo YM,Chamberlain PF.Presence of fetal DNA in maternal plasma and serum.Lancet1997;350:485-7

[2] Alberry M,Jones M.Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.Prenat Diagn2007;27:415-8

[3] Flori E,Gautier E.Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report.Hum Reprod2004;19:723-4

[4] Lo YM,Sun H.Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.Sci Transl Med2010;2:61ra91

[5] Lo YM,Lau TK.Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.Am J Hum Genet1998;62:768-75 PMCID:PMC1377040

[6] Lo YM,Leung TN,Chang AM.Rapid clearance of fetal DNA from maternal plasma.Am J Hum Genet1999;64:218-24 PMCID:PMC1377720

[7] Wulff CB,Rode L,Petersen OB.Danish Fetal Medicine Study GroupRisk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.Ultrasound Obstet Gynecol2016;47:38-44

[8] Salomon LJ,Audibert F.ISUOG Clinical Standards CommitteeISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.Ultrasound Obstet Gynecol2017;49:815-6

[9] Hill M,Karunaratna M,Chitty L.Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.J Genet Couns2014;23:1012-21

[10] Lewis C,Chitty LS.Non-invasive prenatal diagnosis for single gene disorders: experience of patients.Clin Genet2014;85:336-42

[11] Deng C.Factors Affecting the fetal fraction in noninvasive prenatal screening: a review.Front Pediatr2022;10:812781 PMCID:PMC8829468

[12] Pergament E,Zimmermann B.Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.Obstet Gynecol2014;124:210-8 PMCID:PMC4144440

[13] Canick JA,Kloza EM,Haddow JE.The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.Prenat Diagn2013;33:667-74

[14] Jiang P,Liao GJ.FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma.Bioinformatics2012;28:2883-90

[15] Yu SCY,Peng W.Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma.Proc Natl Acad Sci USA2021;118 PMCID:PMC8685924

[16] Lo YM,Chan KC.Digital PCR for the molecular detection of fetal chromosomal aneuploidy.Proc Natl Acad Sci USA2007;104:13116-21 PMCID:PMC1934923

[17] Lo YM.Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis.Clin Chem2008;54:461-6

[18] Ravitsky V,Haidar H.The emergence and global spread of noninvasive prenatal testing.Annu Rev Genomics Hum Genet2021;22:309-38

[19] Wilkins-Haug L,Cerveira E.Biological explanations for discordant noninvasive prenatal test results: preliminary data and lessons learned.Prenat Diagn2018;38:445-58 PMCID:PMC6721610

[20] Hartwig TS,Sørensen S.Discordant non-invasive prenatal testing (NIPT) - a systematic review.Prenat Diagn2017;37:527-39

[21] Winerdal M,Granfors M,Iwarsson E.Confined placental mosaicism of Duchenne muscular dystrophy: a case report.Mol Cytogenet2020;13:51 PMCID:PMC7745369

[22] Hill M,Martin P.Non-invasive prenatal determination of fetal sex: translating research into clinical practice.Clin Genet2011;80:68-75

[23] Devaney SA,Scott JA.Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.JAMA2011;306:627-36 PMCID:PMC4526182

[24] der Schoot CE, Thurik FF, Veldhuisen B, de Haas M. Noninvasive prenatal blood group and HPA-1a genotyping: the current European experience.Transfusion2013;53:2834-6

[25] Clausen FB,Krog GR,Dziegiel MH.Noninvasive Antenatal screening for fetal RHD in RhD negative women to guide targeted anti-D prophylaxis. In: Levy B, editor. Prenatal diagnosis. New York: Springer; 2019. p. 347-59.

[26] Legler TJ,Korschineck I.Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status.Arch Gynecol Obstet2021;304:1191-6 PMCID:PMC8490250

[27] Rieneck K,Clausen FB.Next generation sequencing-based fetal abo blood group prediction by analysis of cell-free DNA from maternal plasma.Transfus Med Hemother2020;47:45-53 PMCID:PMC7036558

[28] Saito H,Morimoto T,Yanaihara T.Prenatal DNA diagnosis of a single-gene disorder from maternal plasma.Lancet2000;356:1170

[29] Amicucci P,Novelli G.Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma.Clinical Chemistry2000;46:301-2

[30] Chitty LS,Meaney C.New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma.Ultrasound Obstet Gynecol2011;37:283-9

[31] Chitty LS,Barrett AN,Griffin DR.Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA.Prenat Diagn2013;33:416-23 PMCID:PMC4166694

[32] Chitty LS,Barrett AN.Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach.Prenat Diagn2015;35:656-62 PMCID:PMC4657458

[33] Mellis R,Jenkins L.The role of sonographic phenotyping in delivering an efficient noninvasive prenatal diagnosis service for FGFR3-related skeletal dysplasias.Prenat Diagn2020;40:785-91

[34] Parks M,Cleary S.Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage.Prenat Diagn2016;36:312-20 PMCID:PMC4864947

[35] Young E,Gerrish A.Clinical service delivery of noninvasive prenatal diagnosis by relative haplotype dosage for single-gene disorders.J Mol Diagn2020;22:1151-61 PMCID:PMC7471768

[36] Chandler NJ,Drury S.Noninvasive prenatal diagnosis for cystic fibrosis: implementation, uptake, outcome, and implications.Clin Chem2020;66:207-16

[37] Parks M,Bowns B.Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage.Eur J Hum Genet2017;25:416-22 PMCID:PMC5386415

[38] Tsao DS,Landry BP.A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT.Sci Rep2019;9:14382 PMCID:PMC6779891

[39] Zhang J,Saucier JB.Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA.Nat Med2019;25:439-47

[40] Hill M,Jenkins L,Elles RG.Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom.Expert Opin Biol Ther2012;12 Suppl 1:S119-26

[41] Hill M,Verhoef TI.Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.Prenat Diagn2015;35:950-8 PMCID:PMC4672687

[42] Pacault M,Lopez M.Non-invasive prenatal diagnosis of single gene disorders by paternal mutation exclusion: 3 years of clinical experience.BJOG2022;129:1879-86

[43] Tardy-Guidollet V,Costa JM.New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).J Clin Endocrinol Metab2014;99:1180-8

[44] New MI,Yuen T.Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.J Clin Endocrinol Metab2014;99:E1022-30 PMCID:PMC4037720

[45] D’Aversa E,Pellegatti P,Gambari R.Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR.Mol Med2018;24:14 PMCID:PMC6016869

[46] Galbiati S,Lalatta F.Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases.Clin Chem2011;57:136-8 PMCID:PMC3040649

[47] Galbiati S,Damin F.COLD-PCR and microarray: two independent highly sensitive approaches allowing the identification of fetal paternally inherited mutations in maternal plasma.J Med Genet2016;53:481-7

[48] Galbiati S,Sbaiz L.Identification of an 18 bp deletion in the TWIST1 gene by CO-amplification at lower denaturation temperature-PCR (COLD-PCR) for non-invasive prenatal diagnosis of craniosynostosis: first case report.Clin Chem Lab Med2014;52:505-9

[49] Byrou S,Christofides A,Papasavva T.Fast Temperature-Gradient COLD PCR for the enrichment of the paternally inherited SNPs in cell free fetal DNA; an application to non-invasive prenatal diagnosis of β-thalassaemia.PLoS One2018;13:e0200348 PMCID:PMC6059429

[50] Mortazavipour MM,Mahdian R.Detection of paternal IVS-II-1 (G>A) (HBB: c.315+1G>A) mutation in cell-free fetal DNA using COLD-PCR assay.Hemoglobin2020;44:168-73

[51] Ferro M,Noguerol P.Non-invasive prenatal diagnosis of feto-maternal platelet incompatibility by cold high resolution melting analysis. In: Gahan PB, Fleischhacker M, Schmidt B, editors. Circulating nucleic acids in serum and plasma - CNAPS IX. Cham: Springer International Publishing; 2016. p. 67-70.

[52] Morrison T,Garcia J.Nanoliter high throughput quantitative PCR.Nucleic Acids Res2006;34:e123 PMCID:PMC1635282

[53] Spurgeon SL,Ramakrishnan R.High throughput gene expression measurement with real time PCR in a microfluidic dynamic array.PLoS One2008;3:e1662 PMCID:PMC2244704

[54] Vogelstein B.Digital PCR.Proc Natl Acad Sci USA1999;96:9236-41 PMCID:PMC17763

[55] Sillence KA,Hollands HJ.Fetal Sex and RHD genotyping with digital PCR demonstrates greater sensitivity than real-time PCR.Clin Chem2015;61:1399-407

[56] Whale AS,Cowen S.Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.Nucleic Acids Res2012;40:e82 PMCID:PMC3367212

[57] Hindson BJ,Masquelier DA.High-throughput droplet digital PCR system for absolute quantitation of DNA copy number.Anal Chem2011;83:8604-10 PMCID:PMC3216358

[58] Tsui NB,Gardener GJ.Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele.Prenat Diagn2013;33:1214-6

[59] Gruber A,El Khattabi LA.Non-invasive prenatal diagnosis of paternally inherited disorders from maternal plasma: detection of NF1 and CFTR mutations using droplet digital PCR.Clin Chem Lab Med2018;56:728-38

[60] Orhant L,Fradin M.Droplet digital PCR combined with minisequencing, a new approach to analyze fetal DNA from maternal blood: application to the non-invasive prenatal diagnosis of achondroplasia.Prenat Diagn2016;36:397-406

[61] Drury S,Mckay F.Implementing non-invasive prenatal diagnosis (NIPD) in a National Health Service Laboratory; From dominant to recessive disorders. In: Gahan PB, Fleischhacker M, Schmidt B, editors. Circulating nucleic acids in serum and plasma - CNAPS IX. Cham: Springer International Publishing; 2016. p. 71-5.

[62] Mohan P,Trotter C.Clinical experience with non-invasive prenatal screening for single-gene disorders.Ultrasound Obstet Gynecol2022;59:33-9 PMCID:PMC9302116

[63] Opinion No. 691: carrier screening for genetic conditions.Obstet Gynecol2017;129:e41-55

[64] Natera. Vistara™ single-gene NIPT. Available from: https://www.natera.com/womens-health/vistara-nipt-single-gene-test/ [Last accessed on 21 Feb 2023]

[65] Mellis R,Scotchman E,Chitty LS.Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: a systematic review and meta-analysis.Prenat Diagn2022;42:662-85 PMCID:PMC9325531

[66] Filer DL,Brandt AT.Pre-capture multiplexing provides additional power to detect copy number variation in exome sequencing.BMC Bioinformatics2021;22:374 PMCID:PMC8293537

[67] Provenzano A,Reho P.Noninvasive prenatal diagnosis in a family at risk for Fraser syndrome.Prenat Diagn2020;40:905-8

[68] Provenzano A,Lai F.Non-invasive detection of a de novo frameshift variant of STAG2 in a female fetus: escape genes influence the manifestation of X-linked diseases in females.J Clin Med2022;11:4182 PMCID:PMC9323000

[69] Camunas-Soler J,Hudgins L.Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR.Clin Chem2018;64:336-45

[70] Perlado S,Donas M,Plaza J.Fetal genotyping in maternal blood by digital PCR: towards NIPD of monogenic disorders independently of parental origin.PLoS One2016;11:e0153258 PMCID:PMC4831728

[71] Lun FM,Chan KC.Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.Proc Natl Acad Sci USA2008;105:19920-5 PMCID:PMC2596743

[72] Constantinou CG,Byrou S.Optimized droplet digital PCR assay on cell-free DNA samples for non-invasive prenatal diagnosis: application to beta-thalassemia.Clin Chem2022;68:1053-63

[73] Shaw J,Paternoster B.Non-invasive fetal genotyping for maternal alleles with droplet digital PCR: a comparative study of analytical approaches.Prenat Diagn2023;Online ahead of print:

[74] Barrett AN,Chan KC.Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia.Clin Chem2012;58:1026-32

[75] Caswell RC,Houghton JAL.Noninvasive fetal genotyping by droplet digital PCR to identify maternally inherited monogenic diabetes variants.Clin Chem2020;66:958-65 PMCID:PMC7611030

[76] Tsui NB,Chan KC.Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA.Blood2011;117:3684-91

[77] Hudecova I,Davies J,Kadir RA.Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.Blood2017;130:340-7 PMCID:PMC5532756

[78] Debrand E,Bradshaw E.A Non-invasive droplet digital PCR (ddPCR) assay to detect paternal CFTR mutations in the cell-free fetal DNA (cffDNA) of three pregnancies at risk of cystic fibrosis via compound heterozygosity.PLoS One2015;10:e0142729 PMCID:PMC4641687

[79] Gu W,Blumenfeld YJ.Noninvasive prenatal diagnosis in a fetus at risk for methylmalonic acidemia.Genet Med2014;16:564-7 PMCID:PMC4079742

[80] Chang MY,Kim MY.Development of novel noninvasive prenatal testing protocol for whole autosomal recessive disease using picodroplet digital PCR.Sci Rep2016;6:37153 PMCID:PMC5141438

[81] Chang MY,Kim MY.One-step noninvasive prenatal testing (NIPT) for autosomal recessive homozygous point mutations using digital PCR.Sci Rep2018;8:2877 PMCID:PMC5811538

[82] Wei X,Tan H,Wu L.Development and validation of a haplotype-free technique for non-invasive prenatal diagnosis of spinal muscular atrophy.J Clin Lab Anal2020;34:e23046 PMCID:PMC7031576

[83] Sawakwongpra K,Ngonsawan W.Droplet-based digital PCR for non-invasive prenatal genetic diagnosis of α and β-thalassemia.Biomed Rep2021;15:82 PMCID:PMC8411484

[84] Tan C,Wang F.A multiplex droplet digital PCR assay for non-invasive prenatal testing of fetal aneuploidies.Analyst2019;144:2239-47

[85] D’Aversa E,Boutou E.Droplet digital PCR for non-invasive prenatal detection of fetal single-gene point mutations in maternal plasma.Int J Mol Sci2022;23:2819 PMCID:PMC8911123

[86] van Campen J,Yau S.A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.Br J Haematol2020;190:119-24

[87] Yang X,Zhou W.A Cell-free DNA Barcode-enabled single-molecule test for noninvasive prenatal diagnosis of monogenic disorders: application to β-thalassemia.Adv Sci (Weinh)2019;6:1802332 PMCID:PMC6548944

[88] Zhao G,Liu L,Kong X.Noninvasive prenatal diagnosis of duchenne muscular dystrophy in five Chinese families based on relative mutation dosage approach.BMC Med Genomics2021;14:275 PMCID:PMC8607717

[89] Lv W,Guo R.Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART).Clin Chem2015;61:172-81

[90] Han M,Wang W.A quantitative cSMART assay for noninvasive prenatal screening of autosomal recessive nonsyndromic hearing loss caused by GJB2 and SLC26A4 mutations.Genet Med2017;19:1309-16

[91] Chen Y,Wang B.Development and validation of a fetal genotyping assay with potential for noninvasive prenatal diagnosis of hereditary hearing loss.Prenat Diagn2016;36:1233-41

[92] Xiong L,Hua R.Non-invasive prenatal testing for fetal inheritance of maternal β-thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study.BJOG2018;125:461-8

[93] Lv W,Li Z.Noninvasive prenatal diagnosis for pregnancies at risk for β-thalassaemia: a retrospective study.BJOG2021;128:448-57

[94] Duan H,Zhao Z.Non-invasive prenatal testing of pregnancies at risk for phenylketonuria.Arch Dis Child Fetal Neonatal Ed2019;104:F24-9

[95] Lv W,Wei X.Noninvasive fetal genotyping in pregnancies at risk for PKU using a comprehensive quantitative cSMART assay for PAH gene mutations: a clinical feasibility study.BJOG2019;126:1466-74

[96] Lv W,Chen X.Noninvasive prenatal testing of methylmalonic acidemia cblC Type using the cSMART assay for MMACHC gene mutations.Front Genet2021;12:750719 PMCID:PMC8777107

[97] Song Y,Huang S.Quantitation of fetal DNA fraction in maternal plasma using circulating single molecule amplification and re-sequencing technology (cSMART).Clin Chim Acta2016;456:151-6

[98] Cutts A,Petrou M.A method for noninvasive prenatal diagnosis of monogenic autosomal recessive disorders.Blood2019;134:1190-3 PMCID:PMC6888147

[99] Riku S,Carozza JA.Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower cost.J Med Econ2022;25:403-11

[100] Hoskovec J,Talati AN.Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions.Genet Med2023;25:100334

[101] Lam KW,Liao GJ.Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia.Clin Chem2012;58:1467-75

[102] Gerrish A,Mashayamombe-Wolfgarten C.Non-invasive prenatal diagnosis of retinoblastoma inheritance by combined targeted sequencing strategies.J Clin Med2020;9:3517 PMCID:PMC7692133

[103] Ma D,Li X.Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing.Gene2014;544:252-8

[104] Xu Y,Ge HJ.Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma.Genet Med2015;17:889-96

[105] West Midlands Regional Genetics Laboratory. NIPD for Congenital adrenal hyperplasia (CAH). Available from: https://bwc.nhs.uk/download.cfm?doc=docm93jijm4n4060.pdf&ver=6057 [Last accessed on 21 Feb 2023]

[106] Hui WW,Tong YK.Universal haplotype-based noninvasive prenatal testing for single gene diseases.Clin Chem2017;63:513-24

[107] Pereira R,Sousa M.Bioinformatics and computational tools for next-generation sequencing analysis in clinical genetics.J Clin Med2020;9:132 PMCID:PMC7019349

[108] Jang SS,Yoo SK.Targeted linked-read sequencing for direct haplotype phasing of maternal DMD alleles: a practical and reliable method for noninvasive prenatal diagnosis.Sci Rep2018;8:8678 PMCID:PMC5989205

[109] Lee JS,Song H.Direct Haplotyping-based noninvasive prenatal test for myotonic dystrophy type 1 with large cTG expansion.Clin Chem2020;66:614-5

[110] Chen C,Zhu Y.Noninvasive prenatal diagnosis of monogenic disorders based on direct haplotype phasing through targeted linked-read sequencing.BMC Med Genomics2021;14:244 PMCID:PMC8502361

[111] Liautard-Haag C,VanGoethem C.Noninvasive prenatal diagnosis of genetic diseases induced by triplet repeat expansion by linked read haplotyping and Bayesian approach.Sci Rep2022;12:11423 PMCID:PMC9259573

[112] de Vree PJ,Yilmaz M.Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.Nat Biotechnol2014;32:1019-25

[113] Vermeulen C,de Wit E.Sensitive monogenic noninvasive prenatal diagnosis by targeted haplotyping.Am J Hum Genet2017;101:326-39 PMCID:PMC5590845

[114] Selvaraj S,Bansal V.Whole-genome haplotype reconstruction using proximity-ligation and shotgun sequencing.Nat Biotechnol2013;31:1111-8 PMCID:PMC4180835

[115] Lefferts JW,Hagemeijer MC,Beekman JM.Targeted locus amplification and haplotyping. In: Peters BA, Drmanac R, editors. Haplotyping. New York: Springer US; 2023. p. 31-48.

[116] Jiang F,Zhang L.Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study.Sci Rep2021;11:5714 PMCID:PMC7952549

[117] Chen X,Farrow E.Genomics England Research ConsortiumComprehensive SMN1 and SMN2 profiling for spinal muscular atrophy analysis using long-read PacBio HiFi sequencing.Am J Hum Genet2023;110:240-50

[118] Grunau C,Rosenthal A.Bisulfite genomic sequencing: systematic investigation of critical experimental parameters.Nucleic Acids Res2001;29:E65-5 PMCID:PMC55789

[119] Tse OYO,Cheng SH.Genome-wide detection of cytosine methylation by single molecule real-time sequencing.Proc Natl Acad Sci USA2021;118 PMCID:PMC7865158

[120] Katsman E,Martignano F.Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing.Genome Biol2022;23:158 PMCID:PMC9283844

[121] Ashoor G,Poon LC,Nicolaides KH.Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: relation to maternal and fetal characteristics.Ultrasound Obstet Gynecol2013;41:26-32

[122] Lun FM,Chan KC,Lau TK.Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma.Clin Chem2008;54:1664-72

[123] Palomaki GE,Lambert-Messerlian GM.DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.Genet Med2011;13:913-20

[124] Norton ME,Weiss J.Non-Invasive chromosomal evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.Am J Obstet Gynecol2012;207:137.e1-8

[125] Hudecova I.Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA.Best Pract Res Clin Obstet Gynaecol2017;39:63-73

[126] Chiu RW,Zheng YW.Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.BMJ2011;342:c7401 PMCID:PMC3019239

[127] Kim SK,Geis J.Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.Prenat Diagn2015;35:810-5

[128] Xu C,Chen S.Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening.Cell Discov2022;8:109 PMCID:PMC9562363

[129] Liao GJ,Zheng YW.Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles.Clin Chem2011;57:92-101

[130] Chan KC,Gerovassili A.Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.Clin Chem2006;52:2211-8

[131] Nygren AO,Jensen TJ.Quantification of fetal DNA by use of methylation-based DNA discrimination.Clin Chem2010;56:1627-35

[132] Lun FM,Sun K.Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA.Clin Chem2013;59:1583-94

[133] Sun K,Chan KC.Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.Proc Natl Acad Sci USA2015;112:E5503-12 PMCID:PMC4603482

[134] Schroeder DI,Lott P.The human placenta methylome.Proc Natl Acad Sci USA2013;110:6037-42 PMCID:PMC3625261

[135] Ioannides M,Kyriakou S.Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR.Mol Genet Genomic Med2020;8:e1094 PMCID:PMC7005606

[136] Yu SC,Zheng YW.Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.Proc Natl Acad Sci USA2014;111:8583-8 PMCID:PMC4060699

[137] Straver R,Sistermans EA.Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.Prenat Diagn2016;36:614-21 PMCID:PMC5111749

[138] Mouawia H,Jais JP.Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.Reprod Biomed Online2012;25:508-20

[139] Bianchi DW,Jackson LG.Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.Prenat Diagn2002;22:609-15

[140] Chen F,Gu Y.Isolation and whole genome sequencing of fetal cells from maternal blood towards the ultimate non-invasive prenatal testing.Prenat Diagn2017;37:1311-21

[141] Hatt L,Christensen R.Cell-based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations.Clin Case Rep2020;8:2561-7 PMCID:PMC7752386

[142] Ravn K,Hatt L.The number of circulating fetal extravillous trophoblasts varies from gestational week 6 to 20.Reprod Sci2020;27:2170-4 PMCID:PMC7593292

[143] Jeppesen LD,Hatt L.Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants.Prenat Diagn2023;43:3-13

[144] Vossaert L,Zemet R.Overview and recent developments in cell-based noninvasive prenatal testing.Prenat Diagn2021;41:1202-14 PMCID:PMC9355411

[145] Cayrefourcq L,Pierredon S.Single circulating fetal trophoblastic cells eligible for non invasive prenatal diagnosis: the exception rather than the rule.Sci Rep2020;10:9861 PMCID:PMC7300110

[146] Chang L,Li R.A novel method for noninvasive diagnosis of monogenic diseases from circulating fetal cells.Prenat Diagn2021;41:400-8

[147] Toft CLF,Kesmodel US.Cell-based non-invasive prenatal testing for monogenic disorders: confirmation of unaffected fetuses following preimplantation genetic testing.J Assist Reprod Genet2021;38:1959-70 PMCID:PMC8417213

[148] Wei X,Guo S,Zhao XZ.Emerging microfluidic technologies for the detection of circulating tumor cells and fetal nucleated red blood cells.ACS Appl Bio Mater2021;4:1140-55

[149] Bianchi DW,Sullivan LM,Klinger KW.PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies.Am J Hum Genet1997;61:822-9 PMCID:PMC1715976

[150] Imudia AN,Kilburn BA.Retrieval of trophoblast cells from the cervical canal for prediction of abnormal pregnancy: a pilot study.Hum Reprod2009;24:2086-92 PMCID:PMC2727404

[151] Bolnick JM,Bajpayee S.Trophoblast retrieval and isolation from the cervix (TRIC) for noninvasive prenatal screening at 5 to 20 weeks of gestation.Fertil Steril2014;102:135-142.e6